Literature DB >> 10728019

Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina.

A D Simon1, S Yazdani, W Wang, A Schwartz, L E Rabbani.   

Abstract

BACKGROUND: Multiple studies support a role for inflammation in the pathogenesis of coronary atherosclerosis and unstable cardiac syndromes. However, of the known proinflammatory cytokines, only elevated plasma levels of interleukin-6 have been linked to unstable angina. We sought to examine the plasma levels of other major proinflammatory cytokines in similar clinical settings and to determine the extent of the relationship between inflammation and unstable coronary syndromes by measuring the levels of various proinflammatory cytokines in patients with stable and unstable angina.
METHODS: We measured plasma levels of interleukin-1 beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), and interleukin 6 (IL-6) in 97 patients: 67 with stable angina, 24 with unstable angina, and 15 healthy controls.
RESULTS: Mean levels of IL-1beta were significantly higher in patients with unstable angina as compared to patients with stable angina (p =.009). Levels of IL-6 were significantly higher than control patients for both stable angina and unstable angina patients (p =.031 and.006, respectively). No significant differences were found in the levels of TNF-alpha.
CONCLUSIONS: Our results suggest that both IL-1beta and IL-6 contribute to the pathogenesis of unstable angina, and that the profile of circulating plasma levels of proinflammatory cytokines differs in unstable angina from that in stable angina. Abbreviated Abstract. Multiple studies support a role for inflammation in the pathogenesis of coronary atherosclerosis and unstable cardiac syndromes. We measured plasma levels of interleukin-1 beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), and interleukin 6 (IL-6) in patients with stable and unstable coronary syndromes. Levels of IL-1beta and IL-6 were found to be elevated in patients with unstable coronary syndromes. No significant differences were found in the levels of TNF-alpha. Our results suggest that both IL-1beta and IL-6 contribute to the pathogenesis of unstable angina.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728019     DOI: 10.1023/a:1018758409934

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  36 in total

1.  Detection and localization of tumor necrosis factor in human atheroma.

Authors:  P Barath; M C Fishbein; J Cao; J Berenson; R H Helfant; J S Forrester
Journal:  Am J Cardiol       Date:  1990-02-01       Impact factor: 2.778

Review 2.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Adv Pharmacol       Date:  1994

3.  Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

Authors:  L M Colletti; D G Remick; G D Burtch; S L Kunkel; R M Strieter; D A Campbell
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

4.  Interleukin-6 stimulates coagulation, not fibrinolysis, in humans.

Authors:  J M Stouthard; M Levi; C E Hack; C H Veenhof; H A Romijn; H P Sauerwein; T van der Poll
Journal:  Thromb Haemost       Date:  1996-11       Impact factor: 5.249

Review 5.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

Authors:  K J Tracey; A Cerami
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

6.  Modulation of endothelial cell functions by different molecular species of interleukin 1.

Authors:  E Dejana; F Breviario; A Erroi; F Bussolino; L Mussoni; M Gramse; G Pintucci; B Casali; C A Dinarello; J Van Damme
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

7.  Comparison of the effects of recombinant interleukin 6 and recombinant interleukin 1 on nonspecific resistance to infection.

Authors:  J W Van der Meer; M Helle; L Aarden
Journal:  Eur J Immunol       Date:  1989-02       Impact factor: 5.532

8.  Elevated levels of interleukin-6 in unstable angina.

Authors:  L M Biasucci; A Vitelli; G Liuzzo; S Altamura; G Caligiuri; C Monaco; A G Rebuzzi; G Ciliberto; A Maseri
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

9.  Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production.

Authors:  C M Hawrylowicz; G L Howells; M Feldmann
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.

Authors:  T van der Poll; M Levi; C E Hack; H ten Cate; S J van Deventer; A J Eerenberg; E R de Groot; J Jansen; H Gallati; H R Büller
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  17 in total

1.  IL1α Antagonizes IL1β and Promotes Adaptive Immune Rejection of Malignant Tumors.

Authors:  Tian Tian; Serena Lofftus; Youdong Pan; Claire A Stingley; Sandra L King; Jingxia Zhao; Timothy Y Pan; Rebecca Lock; Jacob W Marglous; Kevin Liu; Hans R Widlund; Robert C Fuhlbrigge; Karen Cichowski; Thomas S Kupper
Journal:  Cancer Immunol Res       Date:  2020-03-11       Impact factor: 11.151

2.  Subacute inflammatory activation in subjects with acute coronary syndrome and left ventricular dysfunction.

Authors:  Luisa De Gennaro; Natale Daniele Brunetti; Deodata Montrone; Fiorella De Rosa; Andrea Cuculo; Matteo Di Biase
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

3.  Cardiac release and kinetics of cytokines after elective bare metal coronary stenting.

Authors:  NourEddine ElMokhtari; Sascha Zschernitz; Susanne Sebens; Gunhild Simon-Herrmann; Dietmar Krüger
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

Review 4.  Consolidated and emerging inflammatory markers in coronary artery disease.

Authors:  Valter Lubrano; Silvana Balzan
Journal:  World J Exp Med       Date:  2015-02-20

5.  Correlation between interleukin 6 and interleukin 10 in acute myocardial infarction.

Authors:  Larisa Dizdarević-Hudić; Zumreta Kusljugić; Fahir Baraković; Selmira Brkić; Damir Sabitović; Elmir Jahić; Maida Isabegović; Elnur Smajić; Igor Hudić; Katarina Divković
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

6.  Genetic dissection of the pre-eclampsia susceptibility locus on chromosome 2q22 reveals shared novel risk factors for cardiovascular disease.

Authors:  Matthew P Johnson; Shaun P Brennecke; Christine E East; Thomas D Dyer; Linda T Roten; J Michael Proffitt; Phillip E Melton; Mona H Fenstad; Tia Aalto-Viljakainen; Kaarin Mäkikallio; Seppo Heinonen; Eero Kajantie; Juha Kere; Hannele Laivuori; Rigmor Austgulen; John Blangero; Eric K Moses
Journal:  Mol Hum Reprod       Date:  2013-02-18       Impact factor: 4.025

7.  VASCULAR INFLAMMATION AND ATHEROGENESIS ARE ACTIVATED VIA RECEPTORS FOR PAMPs AND SUPPRESSED BY REGULATORY T CELLS.

Authors:  Xiao-Feng Yang; Ying Yin; Hong Wang
Journal:  Drug Discov Today Ther Strateg       Date:  2008

8.  IL1B genetic variation and plasma C-reactive protein level among young adults: the CARDIA study.

Authors:  Daniel A Enquobahrie; Kenneth Rice; O Dale Williams; Michelle A Williams; Myron D Gross; Cora E Lewis; Stephen M Schwartz; David S Siscovick
Journal:  Atherosclerosis       Date:  2008-05-18       Impact factor: 5.162

9.  Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome.

Authors:  T Kilic; D Ural; E Ural; Z Yumuk; A Agacdiken; T Sahin; G Kahraman; G Kozdag; A Vural; B Komsuoglu
Journal:  Heart       Date:  2006-03-17       Impact factor: 5.994

Review 10.  Psychobiology of depression/distress in congestive heart failure.

Authors:  Kaki M York; Mustafa Hassan; David S Sheps
Journal:  Heart Fail Rev       Date:  2008-03-27       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.